SEC Tracker
Get the app

Possible new Annovis Bio shares

ANVSDilution

Known so far: no new shares from the prospectus covers read · shelf room about $12.0M · not yet read: warrants, converts, options, ATM.

Shelf room

  • Room today about $12.0M, maybe lower
  • One third of float $12.0M ($36.1M float, Jun 30, 2025)
  • Sold off it, 12 months nothing
How this is worked out

Shelf room about $12.0M on the S-3 of Feb 12, 2024: the baby-shelf rule (public float under $75M) caps sales at one third of the $36.1M public float stated as of Jun 30, 2025, $12.0M, nothing sold off it in the last 12 months; 3 more sales off the shelf with no size read, so the room may be lower. Sources: S-3/A Feb 12, 2024, effective Feb 12, 2024 · public float, as of Jun 30, 2025 · 424B5 Apr 9, 2026 · 424B5 May 19, 2026 · 424B5 May 20, 2026.

What could become new Annovis Bio (ANVS) shares, from its 10-Q, 10-K, S-3 or 424B filings.

Read so far: the cover share count (42.6M shares, +119% from 19.5M on Aug 8, 2025). Not read yet: warrants, convertible notes, options and RSUs and an ATM program. Read them on EDGAR: the latest 10-Q · S-3 shelf filings.

Shares outstanding

42.6M

Nov 2024 to Aug 2026: from 13.8M to 42.6M.

From the share count on the cover of each 10-Q and 10-K, dated as each cover states.